IWM
VVOS icon

IHT Wealth Management’s Vivos Therapeutics VVOS Stock Holding History

IHT Wealth Management’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.5K Buy
+41,061
New +$65.8K ﹤0.01% 1230
2021
Q3 		– Sell
-493
Closed -$61K – 981
2021
Q2 		$61K Buy
+493
New +$80.3K ﹤0.01% 920

Other funds holding VVOS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
CWM
Centurion Wealth Management Mclean, Virginia $418M AUM 23.14% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IHT Wealth Management's VVOS Position: Q1 2026 in Review

IHT Wealth Management opened a new position in Vivos Therapeutics (VVOS) in Q1 2026: 41,061 shares worth $48.5K. The stake represents ﹤0.01% of the portfolio and ranks #1230 among its holdings. This is a return to the name: IHT Wealth Management previously reported a position in VVOS as recently as Q2 2021.

IHT Wealth Management first reported a position in VVOS in Q2 2021 and has held it in 2 quarters since. The position peaked at $61K in Q2 2021. 24 funds tracked by Wall St. Rank hold VVOS as of Q1 2026.

  • IHT Wealth Management held 41,061 shares of Vivos Therapeutics worth $48.5K as of Q1 2026.
  • Vivos Therapeutics was a new IHT Wealth Management position in Q1 2026.
  • Vivos Therapeutics made up ﹤0.01% of IHT Wealth Management's portfolio in Q1 2026, its #1230 holding.
  • IHT Wealth Management first reported a position in Vivos Therapeutics in Q2 2021 and has held it in 2 quarters since.
  • IHT Wealth Management's Vivos Therapeutics position peaked at $61K in Q2 2021.
  • 24 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q1 2026.

Based on IHT Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.